Bazzoni Riccardo, Takam Kamga Paul, Tanasi Ilaria, Krampera Mauro
Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
EA4340-BCOH, Biomarker in Cancerology and Onco-Haematology, UVSQ, Université Paris Saclay, Boulogne-Billancourt, France.
Front Cell Dev Biol. 2020 Nov 6;8:596079. doi: 10.3389/fcell.2020.596079. eCollection 2020.
Mesenchymal stem/stromal cells (MSCs) are multipotent cells residing in the stromal tissues of the body and capable of promoting tissue repair and attenuating inflammatory processes through their immunomodulatory properties. Preclinical and clinical observations revealed that not only direct intercellular communication mediates MSC properties; in fact, a pivotal role is also played by the release of soluble and bioactive factors, such as cytokines, growth factor and extracellular vesicles (EVs). EVs are membrane-coated vesicles containing a large variety of bioactive molecules, including lipids, proteins, and nucleic acids, such as RNA. EVs release their contents into target cells, thus influencing cell fate through the control of intracellular processes. In addition, MSC-derived EVs can mediate modulatory effects toward different effector cells belonging to both innate and adaptive immunity. In this review, we will discuss the literature data concerning MSC-derived EVs, including the current standardized methods for their isolation and characterization, the mechanisms supporting their immunoregulatory properties, and their potential clinical application as alternative to MSC-based therapy for inflammatory reactions, such as graft-versus-host disease (GvHD).
间充质干/基质细胞(MSCs)是存在于机体基质组织中的多能细胞,能够通过其免疫调节特性促进组织修复并减轻炎症过程。临床前和临床观察表明,不仅直接的细胞间通讯介导了MSCs的特性;事实上,可溶性生物活性因子如细胞因子、生长因子和细胞外囊泡(EVs)的释放也发挥着关键作用。EVs是包被有膜的囊泡,包含多种生物活性分子,如脂质、蛋白质和核酸(如RNA)。EVs将其内容物释放到靶细胞中,从而通过控制细胞内过程影响细胞命运。此外,源自MSCs的EVs可介导对属于固有免疫和适应性免疫的不同效应细胞的调节作用。在本综述中,我们将讨论有关源自MSCs的EVs的文献数据,包括其分离和表征的当前标准化方法、支持其免疫调节特性的机制,以及它们作为基于MSCs的疗法的替代方案用于移植物抗宿主病(GvHD)等炎症反应的潜在临床应用。